计算机辅助决策支持系统的阿尔茨海默病诊断 - 一个系统的审查
Tuğba Günaydın1, Songül Varlı1
1Department of Computer Engineering, Yıldız Technical University, Istanbul, Türkiye.
Current medical imaging
|June 4, 2025
概括
计算机辅助系统在早期发现阿尔茨海默病方面表现有前途. 多模式数据和先进的机器学习提高了诊断准确性,但数据不平衡等挑战需要解决.
科学领域:
- 医疗信息学 医疗信息学
- 人工智能在医学中的应用
- 神经科学是一个神经科学.
背景情况:
- 随着人口老龄化,阿尔茨海默病 (AD) 的发病率在全球范围内正在增加.
- 早期AD诊断对于减缓疾病进展至关重要,因为目前还没有治愈方法.
- 计算机辅助诊断系统是提高早期AD检测的重要工具.
研究的目的:
- 系统地审查最近在AD诊断的计算机辅助决策支持系统的进展.
- 在AD分类中评估数据模式,机器学习方法和性能指标.
- 确定该领域的当前趋势和局限性.
主要方法:
- 系统审查遵循系统审查和元分析 (PRISMA) 准则的首选报告项目.
- 在PubMed,IEEEEXplore和科学网络中从2021年至2024年进行文献搜索.
- 包括39项使用神经成像 (MRI,PET) 和机器学习的生物标志物用于AD分类的研究.
主要成果:
- 多模式方法 (MRI,PET,认知评估) 显示出比单一模式更高的诊断准确性和可靠性.
- 卷积神经网络是最普遍的机器学习模型,其次是混合和随机森林模型.
- 报告的准确度很高:对二进制的分类高达100%,对多类AD分类高达99.98%. 像合成少数人过量采样技术 (SMOTE) 和数据增强等技术解决了数据不平衡.
结论:
- 多模式数据集成显著提高了计算机辅助AD诊断的准确性.
- 关键的局限性包括数据不平衡,样本规模小,外部验证不足.
- 未来的研究应该专注于更大,多样化的数据集,纵向数据,现实世界的临床验证和临床信任的模型可解释性.
相关概念视频
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
Dementia
182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
182


